Publications by authors named "Jingyan Meng"

Claim this Profile
E
Exploring novel strategies of oncolytic viruses and gut microbiota to enhance CAR-T cell therapy for colorectal cancer.
Jia Yi, Sangmu Quji, Luxuan Guo, Zhongqiu Chai, Xianbin Kong, Jingyan Meng

Cell Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zhenqi Fuzheng Granule targets the SCFAs-GPR109A axis to enhance PD-1 antibody efficacy via immunometabolic remodeling in colorectal cancer.
Luxuan Guo, Jia Yi, Ao Zhang, Xiaoqing Zheng, Miao Wang, Jingyan Meng

Phytomedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motor learning improvement by matching visual-haptic error modulation to individual skill level and motivation.
Guang Zhou, Jingyan Meng, Liang Tao, Dazheng Zhao, Feifei Ge

Acta Psychol (Amst)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial intelligence accelerates the identification of nature-derived potent LOXL2 inhibitors.
Xiaowei Jia, Meng Liu, Yushi Tang, Jingyan Meng, Ruolin Fang

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression.
Dong Wang, Yan Zhang, Qingbo Li, Yu Li, Wen Li, Jingyan Meng

Genes Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Qizhen decoction-mediated maturation of DC cells to activate the IL-12/JAK2/STAT4 pathway to sensitise PD-1 inhibitors in the treatment of colorectal cancer.
Xianbin Kong, Qingbo Li, Dong Wang, Miao Wang, Fan Yang, Jingyan Meng

J Ethnopharmacol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Research on mode adjustment control strategy of upper limb rehabilitation robot based on fuzzy recognition of interaction force].
Guoning Li, Liang Tao, Jingyan Meng, Sijia Ye, Guang Feng

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications.
Dong Wang, Yan Zhang, Qingbo Li, Ao Zhang, Jingxuan Xu, Jingyan Meng

Biomed Pharmacother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MCR-ALS-based muscle synergy extraction method combined with LSTM neural network for motion intention detection.
Dazheng Zhao, Yehao Ma, Jingyan Meng, Yang Hu, Mengqi Hong

Front Neurorobot· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fuzzy Adaptive Passive Control Strategy Design for Upper-Limb End-Effector Rehabilitation Robot.
Yang Hu, Jingyan Meng, Guoning Li, Dazheng Zhao, Guang Feng

Sensors (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention.
Dong Wang, Fangyuan Wang, Xianbin Kong, Qingbo Li, Haoyang Shi, Jingyan Meng

Biomed Pharmacother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gamble between oncolytic virus therapy and IFN.
Qingbo Li, Fengxian Tan, Yuanyuan Wang, Xiaohui Liu, Xianbin Kong, Jingyan Meng

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of UPLC-Q-TOF/MS and Network Pharmacology to Reveal the Mechanism of Qizhen Decoction in the Treatment of Colon Cancer.
Xianbin Kong, Chuanxin Liu, Peng Lu, Yuzhu Guo, Chenchen Zhao, Jingyan Meng

ACS Omega· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of PD‑1/PD‑L1 inhibitors: The prospect of overcoming the weakness of tumor immunotherapy (Review).
Xianbin Kong, Peng Lu, Chuanxin Liu, Yuzhu Guo, Yuying Yang, Jingyan Meng

Mol Med Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential role of ZEB1 as a DNA repair regulator in colorectal cancer cells revealed by cancer-associated promoter profiling.
Miao Wang, Su-Fei He, Lei-Lei Liu, Xiao-Xia Sun, Fan Yang, Jing-Yan Meng

Oncol Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
Xihuang Pill () induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB loop.
Miao Wang, Jing-yan Meng, Su-fei He

Chin J Integr Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis